Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Dora Clayton-Jones, RN, PhD, CPNP-PC
Researcher Assistant Professor
Marquette University
Emory T. Clark Hall, 265
Milwaukee, Wisconsin, United States
Dr. Dora Clayton-Jones is an Assistant Professor at Marquette University. She is also the Founder of Children First Angelic Foundation, Inc. with a mission to support children and families of diverse backgrounds and encourage holistic development.
Her research interest is in promoting spirituality and health in adolescents, self-management of chronic conditions, health disparities and equity, qualitative research, and community-based participatory research.
Dr. Clayton-Jones is also an author, minister, certified pediatric nurse practitioner, and educator. She has presented in the community on several topics related to child and adolescent health, child development, ministering to children in the hospital, and helping children grieve. She examines the health care transition experiences of adolescents and emerging adults living with sickle cell disease and ways to promote their self-efficacy and transition readiness. She is a board certified pediatric nurse practitioner and works to promote health equity.
Representative Publications:
Spirituality and Religiosity in Adolescents Living With Sickle Cell Disease
Related Content
-
IASCNAPA Sickle Cell Disease Conference: Treating the Whole PersonDate: April 14-15, 2021 Place: Online/V...
-
International Association of Sickle Cell Nurses and Professional AssociatesThe International Association of Sickle ...
-
Sickle Cell Disease Can’t Stop Alliyahhttps://www.youtube.com/watch?v=pcFdP9cq...
-
Implementation of an Educational Intervention to Optimize Self-Management and Transition Readiness in Young Adults W...Background: The transition from the ped...
-
Increasing Educational Attainment in Adolescents with Sickle Cell DiseaseAdolescents with sickle cell disease (SC...
-
Donna J. Ezell, RNDonna is the Clinical Director at Arkans...
-
Voxelotor can Promote Long-Term Benefits in Teens, Adults With SCD, Latest Clinical Data ShowGlobal Blood Therapeutics’ lead therap...